Siemens CT scan comparisson5

Stratasys is collaborating with Siemens Healthineers in a Landmark Research Project to advance medical imaging

 

The use of 3D printing can improve outcomes by providing 3D modeling to physicians with real-world scenarios to practice and reference.

EDEN PRAIRIE, Minnesota & REHOVOT, Israel, November 27, 2023–(BUSINESS WIRE)–Stratasys Ltd. (NASDAQ: SSYS), a leader in polymer 3D printing and additive manufacturing solutions, today announced it is partnering with Siemens Healthineers to conduct a groundbreaking research project designed to develop new state-of-the-art solutions develop for the advancement of medical imaging phantoms for computed tomography (CT) imaging.

CT phantoms are a crucial tool in medical imaging and a nearly universal resource in hospitals around the world. They are specialized devices used to evaluate and ensure the performance of CT scanners. Phantoms are designed to simulate certain characteristics of the human body and enable the assessment of several key metrics, including radiation dose and image quality, facilitating calibration and ensuring consistent scanner performance. The joint development uses Stratasys’ PolyJet™ technology in combination with Siemens Healthineers’ unique RadioMatrix™ technology and advanced algorithm, aimed at translating scanned patient images into specific radiopacity material characteristics of the human anatomy. The solution enables custom phantom production and the creation of ultra-realistic human anatomy characteristics with complete radiographic accuracy of patient-specific pathology that was previously not possible.

This joint project will transform the way phantoms can be used in the medical field, and in some cases even allow device manufacturers and academic institutions to replace human cadavers with 3D printed structures. Having this capability enables critical efficiency and minimizes unavoidable human variability. This work will also generate a critical amount of research data, providing important insights for advancing CT system algorithms, driving materials development and unlocking potential new application areas – and identifying future research opportunities.

“The current limitations of phantoms have long been a challenge for the radiology community,” said Erez Ben Zvi, Vice President of Medical at Stratasys. “This collaboration with Siemens Healthineers will allow us to jointly explore the tremendous potential of our radiopaque materials and 3D printing technologies to overcome these barriers.”

Starting with the production of 3D printed phantoms for smaller scale anatomies of the head and neck region, the research will include the production of increasingly larger and more complex anatomies – leading to the Phase One endpoint of 3D printing a heart model and a complete human torso with full radiographic accuracy.

“The knowledge gained from this project represents a breakthrough in medical imaging that will open new possibilities for 3D printing and imaging applications,” said Lampros Theodorakis, Head of Computed Tomography Product & Clinical Marketing at Siemens Healthineers. “We are excited about the opportunities that await us as a result of this collaboration and believe it will have long-term implications for medical and academic applications.”

About Stratasys

Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products, healthcare, fashion and education. Through smart and connected 3D printers, polymer materials, a software ecosystem and on-demand parts, Stratasys solutions deliver competitive advantages at every stage of the product value chain. The world’s leading organizations turn to Stratasys to transform product design, make manufacturing and supply chains more agile, and improve patient care.

For more information about Stratasys, visit www.stratasys.com, the Stratasys blog, X/Twitter, LinkedIn or Facebook. Stratasys reserves the right to use any of the foregoing social media platforms, including the Company’s websites, to share material, non-public information pursuant to the SEC’s Regulation FD. To the extent necessary and required by applicable law, Stratasys will also include such information in its public disclosure filings.

Note to editors: High-resolution images and additional information are available upon request from the appropriate media contacts listed.

Contacts

Investor and media contacts

Stratasys Business &
North America
Chris Reese
chris.reese@stratasys.com
+1 6651 357 0877

Investor Relations
Jonah Lloyd
Yonah.Lloyd@stratasys.com
+972 74 745 4919

Europe, the Middle East and Africa
Jonathan Wake / Samantha White,
Incus Media
stratasys@incus-media.com
+44 1737 215200

Brazil, Central America and South America
Erica Massini
Erica.Massini@stratasys.com
+55 (11) 2626-9229

Stratasys Corporate & Israel
Erik Snider
Erik.Snider@stratasys.com
+972 74 745 6053

Asia
Kalyani Dwivedi
Kalyani.Dwivedi@stratasys.com
+91 80 6746 2606

Source link

Similar Posts

  • | |

    Why did I lose all my muscle after my ACL surgery? Video

      After anterior cruciate ligament surgery or ACL surgery, you experience loss of muscle mass. You may have spent a few weeks or months building up your muscles after your ACL injury, so you may have assumed that your muscles would be strong and healthy after surgery. However, there are many reasons why you may…

  • Colorful fresh food improves athletes’ vision

      Nutrition is an important part of the training program of every top athlete. And now, a new study from researchers at the University of Georgia suggests that supplementing athletes’ diets with colorful fruits and vegetables could improve their visual range. The article, which was published in Exercise and Sports Science Reviewsinvestigates how a group…

  • Many types of leisure activities can lower the risk of death for older adults

      Older adults who participate in many different types of leisure activities every week, such as walking, jogging, swimming laps or playing tennis, may have a lower risk of death from any cause, as well as death from cardiovascular disease and cancer. according to a new study led by researchers at the National Cancer Institute,…

  • |

    Knee replacement age limit

    Is there a magic number that determines when you’re too old for a joint procedure? This is one of the most common questions we hear from individuals struggling with persistent pain. Many believe a strict cutoff exists. In reality, the decision for this surgical intervention is far more nuanced. Nearly one million of these procedures are performed each year in the United States. knee replacement age limit discussion We find the timing is based on your unique health profile, not just the calendar. Your specific joint condition and how it impacts your daily mobility are the true guides. While concerns about being “too old” are frequent, we see successful outcomes across a wide spectrum of years. The focus should be on your overall wellness and the level of disability you’re experiencing. Key Takeaways There is no universal, strict age cutoff for considering a joint procedure. The decision is highly individual, based on health and lifestyle factors. Successful outcomes are achieved for patients of various ages. Your specific level of pain and disability is a more critical factor than your birth year. Nearly one million of these surgeries are performed annually in the U.S. A consultation focuses on your overall wellness, not just a number. Understanding Knee Replacement Surgery When pain from joint degeneration becomes debilitating, many consider surgical intervention as a viable solution. This procedure, formally called arthroplasty, removes damaged bone and cartilage. Artificial implants are then secured to restore smooth movement. understanding knee replacement surgery What Is Knee Replacement? Arthroplasty is a major operation performed by orthopedic specialists. During this surgery, the ends of the thigh and shin bones are reshaped. Metal and plastic components are fixed in place to create a new joint surface. The goal is to eliminate discomfort and improve mobility. According to Toni Golen, M.D., and Hope Ricciotti, M.D., these artificial joints typically function well for 15 to 20 years. This durability influences the timing of the operation. Who Are the Ideal Candidates? We identify suitable candidates based on several key factors. The severity of arthritis discomfort is a primary consideration. Individuals whose chronic pain persists despite medications or injections are often good candidates. Doctors also examine how the joint has deteriorated over time. When non-surgical options no longer provide relief, this procedure may be recommended. Research shows 80% to 90% of individuals report positive outcomes after their operation. Evaluation Factor Description Importance Level Pain Level Chronic discomfort that limits daily activities High Treatment Response Lack of improvement with conservative therapies High Joint Damage Visible degeneration on X-rays or scans High Overall Health Ability to tolerate anesthesia and recovery Critical Activity Goals Desire to return to specific functions Moderate Younger patients may be advised to wait for optimal timing. This ensures the implant lasts for many years. The decision ultimately balances current suffering with long-term health outcomes. Medical Factors Beyond Age Medical professionals look beyond the calendar to evaluate a person’s fitness for a major joint operation. Your specific health profile and daily function are the true guides. Overall Health and Its Role We emphasize that your overall health is critical. It determines if you can handle the demands of surgery and recovery. Clinics like Integrity Spine & Orthopedics stress trying conservative options first. These treatments include physical therapy and joint injections for pain relief. Exhausting these paths is a key step before considering an operation. medical factors beyond…

  • |

    Nanovis announces the formation of a Scientific Advisory Board to advance the FDA-designated nanotechnology surface

      The formation of the board comes at a pivotal time for Nanovis as they continue their ongoing mission to leverage nanotechnology for improved patient care. COLUMBIA CITY, Ind., Nov. 2, 2023 /PRNewswire-PRWeb/ — Nanovis, a leader in nanotechnology surface solutions for orthopedic, spinal and dental applications, announces the formation of its Scientific Advisory Board…

  • Tested positive for COVID? Be careful out there

      Higher concussion rates following COVID-19 infection in high school athletes. Bullock GS, Emery CA, Nelson VR, etc. al, Br J Sports Med2023; [epub ahead of print]. two: 10.1136/brjsports-2022-106436. Full text freely available Take home message Athletes who tested positive for a COVID-19 infection were more likely to suffer a concussion within 60 days of…

Leave a Reply

Your email address will not be published. Required fields are marked *